Sinus Lift With Hydroxyapatite Nano Particles Versus Tenting Technique

Schneiderian Membrane Elevation and Augmentation With Hydroxyapatite Nano Particles [ Nano Streams ] Versus Graft Less Tenting Technique With Simultaneous Implant Placement: Randomized Clinical Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03177876

Enrollment

Registered

2017-06-06

Start date

2016-07-31

Completion date

2017-07-31

Last updated

2017-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Sinus Lift

Keywords

tenting Hydroxyapetite nano particles implant immediate

Brief summary

twenty recruited patients indicated for sinus augmentation and immediate implant placement will be divided into two groups (10 in each of the two groups), to compare bone formation and implant stability after shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles \[Nanostreams\] or augmentation with graft less tenting technique with simultaneous implant placement.

Interventions

PROCEDUREsinus lift implant placement Hydroxyapatite Nano particles

shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles with simultaneous implant placement

PROCEDUREsinus lift implant placement tenting

shneiderian membrane elevation and augmentation with graft less tenting technique with simultaneous implant placement

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patients with atrophic maxilla and pneumatization of the maxillary sinus with residual bone height at least 5mm of residual ridge as per MISCH criteria * Both sexes

Exclusion criteria

* Sinus pathology * Heavy smokers more than 20 cigarettes per day * Patients with systemic disease that may affect normal healing

Design outcomes

Primary

Measure	Time frame	Description
patient satisfaction	7 days post operative	evaluation of post operative complications in terms of pain and edema using patient pain chart

Secondary

Measure	Time frame	Description
implant stability	will be measured intra-operative after implant insertion and will be measured one more time 6 months after the first operation at the time of implant exposure	measurement of the implant stability using osstell device
height of bone gain or loss around the implant	6 months post operative	two cone beam CT will be taken for the patients, one immediate post operative and the other 6 months post-operative then the amount of bone gained or loss will be assessed by superimposing the same section in the two cone beam CT

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026